All-round standardized solutions cover cellular screening, molecular biomarker testing and in vivo animal model ...

BioHarvest Sciences (NASDAQ:BHST) reports today. Explore the key operating questions around commercial molecule production and research, business execution, demand quality, and financial flexibility.

BioHarvest Sciences (NASDAQ:BHST) reports today. Explore the key operating questions around data-led molecule development and scalable production, business execution, demand quality, and financial ...

You don’t need to be a gym bro to enjoy the benefits of strength training. But there are some things you need to know ...

Full-year 2026 revenue and adjusted EPS guidance were increased based on first-half momentum and projected higher Eliquis growth of 20% to 25%. The milvexian atrial fibrillation study readout is now ...

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today reported financial results for the second quarter 2026 and provided a business update. “Mirum delivered another strong ...

Greetings, and welcome to Azenta Q3 2026 Fiscal Financial Results. [Operator Instructions] As a reminder, this conference is being recorded, Wednesday, August 5, 2026. I will now turn the conference ...

Good day, and thank you for standing by. Welcome to the Bicara Therapeutics Second Quarter 2026 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being ...

Severe mental disorders like major depressive disorder, bipolar disorder, and schizophrenia share a genetic overlap with ...

Key Points Interested in Nuvation Bio Inc.? Here are five stocks we like better. IBTROZI momentum strengthened: Second-quarter revenue reached $31.7 million, including $23.2 million in U.S ...

Spread the loveImagine a world where the sun’s warmth, captured on a bright summer day, could be released to heat your home ...

Spread the love“`html Imagine a future where new medicines aren’t just discovered, but designed from scratch, tailored with ...